De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV‐positive oropharyngeal carcinoma
References
Additional references
Adelstein DJ, Li Y, Adams GL, Wagner Jr H, Kish JA, Ensley JF, et al. An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. Journal of Clinical Oncology 2003;21(1):92‐8.
Adelstein DJ, Ridge JA, Brizel DM, Holsinger FC, Haughey BH, O'Sullivan B, et al. Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6‐7, 2011, Arlington, Virginia. Head and Neck 2012;34(12):1681‐703.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen‐Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine 2010;363(1):24‐35.
Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al. Meta‐analysis of chemotherapy in head and neck cancer (MACH‐NC): a comprehensive analysis by tumour site. Radiotherapy Oncology 2011;100(1):33‐40.
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology 2011;29(32):4294‐301.
Chaturvedi AK, Anderson WF, Lortet‐Tieulent J, Curado MP, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. Journal of Clinical Oncology 2013;31(36):4550‐9.
Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, et al. Late esophageal toxicity after radiation therapy for head and neck cancer. Head and Neck 2010;32(2):178‐83.
Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clinical Cancer Research 2009;15:6758‐62.
de Martel C, Ferlay F, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncology 2012;13(6):607‐15.
Masterson L, Dwivedi RC, Allam M, Jani P. An adult with a neck lump. BMJ 2013;347:f5473.
Evans M, Powell NG. The changing aetiology of head and neck cancer: the role of human papillomavirus. Clinical Oncology 2010;22:538‐46.
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus‐positive head and neck squamous cell carcinoma in a prospective clinical trial. Journal of the National Cancer Institute 2008;100(4):261‐9.
Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, et al. Long‐term results of RTOG 91‐11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. Journal of Clinical Oncology 2013;31(7):845‐52.
Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus‐positive head and neck squamous cell carcinoma. Journal of Clinical Oncology 2015;33(29):3235‐42.
Haigentz M, Silver CE, Corry J, Genden EM, Takes RP, Rinaldo A, et al. Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. European Archives of Oto‐rhino‐laryngology 2009;266(12):1845‐55.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Haughey BH, Hinni ML, Salassa JR, Hayden RE, Grant DG, Rich JT, et al. Transoral laser microsurgery as primary treatment for advanced stage oropharyngeal cancer: a United States Multicentre Study. Head and Neck 2011;33(12):1683‐94. [DOI: 10.1002/hed.21669]
Holsinger FC, Ferris RL. Transoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers and clinical trials. Journal of Clinical Oncology 2015;33(29):3285‐92.
Howard J, Masterson L, Dwivedi RC, Riffat F, Benson R, Jefferies S, et al. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal carcinoma. Cochrane Database of Systematic Reviews 2016, Issue 12. [DOI: 10.1002/14651858.CD010963.pub2]
Huang S, O'Sullivan B. Temporal regression of cervical lymph node in N2‐N3 head‐and‐neck cancer treated with primary radiation therapy +/‐ chemotherapy: stratified by HPV status. International Journal of Radiation Oncology, Biology, Physics 2012;1:S205.
Hutcheson KA, Bhayani MK, Beadle BM, Gold KA, Shinn EH, Lai SY, et al. Use it or lose it: eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers. JAMA Otolaryngology, Head and Neck Surgery 2013;139(11):1127‐34. [10.1001/jamaoto. 2013.4715.]
Kelly JR, Husain ZA, Burtness B. Treatment de‐intensification strategies for head and neck cancer. European Journal of Cancer 2016;68:125‐33. [DOI: 10.1016/j.ejca.2016.09.006]
Lee MK, Nalliah RP, Kim MK, Elangovan S, Allareddy V, Kumar‐Gajendrareddy P, et al. Prevalence and impact of complications on outcomes in patients hospitalized for oral and oropharyngeal cancer treatment. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2011;112(5):581‐91.
Leonhardt FD, Quon H, Abrahao M, O'Malley Jr BW, Weinstein GS. Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient‐reported quality of life and function. Head and Neck 2012;34(2):146‐54.
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. Journal of Clinical Oncology 2008;26(21):3582‐9. [DOI: 10.1200/JCO.2007.14.8841; PUBMED: PMC4911537]
Masterson L, Moualed D, Liu ZW, Howard JE, Dwivedi RC, Tysome JR, et al. De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma: a systematic review and meta‐analysis of current clinical trials. European Journal of Cancer 2014;50(15):2636‐48. [DOI: 10.1016/j.ejca.2014.07.001.]
Masterson L, Moualed D, Masood A, Dwivedi RC, Benson R, Sterling JC, et al. De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD010271.pub2]
Masterson L, Sorgeloos F, Winder D, Lechner M, Marker A, Malhotra S, et al. Deregulation of SYCP2 predicts early stage HPV+ oropharyngeal carcinoma – a prospective whole transcriptome analysis. Cancer Science 2015;106(11):1568‐75.
Mehanna H, Beech T, Nicholson T, El‐Hariry I, McConkey C, Paleri V, et al. The prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer: a systematic review and meta‐analysis of trends by time and region. Head and Neck 2013;35(5):747‐55. [DOI: 10.1002/hed.22015]
Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope 2009;119(11):2156–64. [DOI: 10.1002/lary.20647]
Moore EJ, Hinni ML. Critical review: transoral laser microsurgery and robotic‐assisted surgery for oropharynx cancer including human papillomavirus‐related cancer. International Journal of Radiation Oncology, Biology, Physics 2013;85(5):1163‐7. [PUBMED: 23182390]
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.
Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Villaret DB, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002;94(11):2967‐80. [PUBMED: 12115386]
Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, et al. Fundamental differences in cell cycle deregulation in human papillomavirus‐positive and human papillomavirus‐negative head/neck and cervical cancers. Cancer Research 2007;67:4605‐19.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schache AG, Powell N, Cuschieri K, Robinson M, Leary S, Mehanna H, et al. HPV‐related oropharynx cancer in the United Kingdom ‐ an evolution in the understanding of disease aetiology. Cancer Research 2016;76:1‐9. [DOI: 10.1158/0008‐5472.CAN‐16‐0633; PUBMED: 27569214]
Siegel RL, Miller KD, Jemal A. Cancer Statistics 2016. CA: a Cancer Journal for Clinicians 2016;66(1):7‐30.
Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clinical Cancer Research 2006;12(3):701‐9.
Sudhoff HH, Schwarze HP, Winder D, Steinstraesser L, Gormer M, Stanley M, et al. Evidence for a causal association for HPV in head and neck cancers. European Archives of Oto‐Rhino‐Laryngology 2011;268:1541–7.
WHO. International Classification of Diseases for Oncology (ICD‐O). 3rd Edition. Geneva: World Health Organization, 2000.
